This lesson-filled episode makes the case for capital "H" History as an investor's secret weapon -- and for why perspective, patience, and precise thinking continue year after year to help investors crush stock market averages.
While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing.
Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.
As the trading floor lights flickered to life in early 2026, a new psychological benchmark took hold of the financial world: 8,000. Just two years after the S&P 500 first crossed the 5,000 threshold, a growing chorus of Wall Street’s most influential strategists is projecting that
As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary barometer for the multi-trillion-dollar U.S. medical sector. On January 12, 2026, the company issued a critical
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
The first trading week of 2026 has delivered a complex narrative for the technology sector, defined by a stark contrast between groundbreaking innovation and a massive institutional shift in capital. As the world gathered for the Consumer Electronics Show (CES) in Las Vegas, Nvidia Corp. (NASDAQ: NVDA) once again seized
As the first week of 2026 comes to a close, the financial markets are undergoing a significant structural shift. The broad-based "rising tide" that lifted almost all sectors throughout 2025 has begun to fragment, giving way to a more discerning "Internal Repair" phase. Investors are increasingly rotating capital out of
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q3, starting with LeMaitre (NASDAQ:LMAT).
